Problems With Understanding Chlamydia Trachomatis Immunology
Overview
Authors
Affiliations
The payoff for understanding Chlamydia trachomatis immunology is the development of a vaccine. Two lines of research have contributed to our current understanding of C. trachomatis immunology. The first is the Grayston model of type-specific immunity and genus-specific pathology, which was elaborated by Caldwell and Morrison as the major outer membrane protein and heat shock protein 60 paradigm. The second is the murine model of Chlamydia muridarum infection, which established the essential role of major histocompatibility complex class II and CD4 T cells in immunity. However, neither approach has yielded a vaccine. I review these 2 lines of research and conclude with 6 problem areas in human C. trachomatis immunology whose resolution may result in a vaccine.
Impact of a potential Chlamydia vaccine in the USA: mathematical modelling analyses.
Makhoul M, Ayoub H, Awad S, Chemaitelly H, Abu-Raddad L BMJ Public Health. 2025; 2(1):e000345.
PMID: 40018092 PMC: 11812766. DOI: 10.1136/bmjph-2023-000345.
Profile of vaccine research: A bibliometric analysis.
Wang X, Wang Q, Gao Y, Jiang L, Tang L Hum Vaccin Immunother. 2025; 21(1):2459459.
PMID: 39906958 PMC: 11801346. DOI: 10.1080/21645515.2025.2459459.
The SWIB domain-containing DNA topoisomerase I of mediates DNA relaxation.
Shen L, Diggs C, Ferdous S, Santos A, Wolf N, Terrebonne A bioRxiv. 2024; .
PMID: 39677648 PMC: 11642884. DOI: 10.1101/2024.12.03.626651.
Meewes C, Gupta K, Geisler W Microbes Infect. 2024; 26(8):105397.
PMID: 39025257 PMC: 11609027. DOI: 10.1016/j.micinf.2024.105397.
Kiekens C, Morre S, Vanrompay D Microorganisms. 2024; 12(6).
PMID: 38930578 PMC: 11205628. DOI: 10.3390/microorganisms12061196.